DocGo announced that the following members of DocGo’s leadership have recently purchased shares on the open market, as follows: Norman Rosenberg, DocGo CFO, purchased a total of 10,000 shares of DocGo’s common stock on March 14 at an average price of $3.61 per share. Steven Katz, director and incoming Chair of the Board purchased a total of 13,500 shares of DocGo’s common stock on March 15 at a price of $3.64 per share. Mr. Katz has been a member of DocGo’s Board of Directors and Chair of the Audit and Compliance Committee since November 2021, and the Lead Independent Director since April 2023. Michael Burdiek, a long-standing member of DocGo’s Board of Directors and Audit and Compliance Committee, purchased a total of 10,000 shares of DocGo’s common stock on March 14, 2024 at a price of $3.61 per share. “These purchases are a further demonstration of our belief in DocGo’s strong business fundamentals and future prospects,” said Lee Bienstock, CEO of DocGo. “I was unable to purchase shares during our most recent trading window due to certain trading restrictions, but I am very much looking forward to purchasing shares – subject to market conditions – as soon as I am able.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DCGO:
- DocGo enters 10b5-1 trading plan for additional $10M stock repurchase program
- DocGo Announces Leadership Shuffle and New Board Chair
- 3 Best Stocks to Buy Now, 3/1/2024, According to Top Analysts
- DocGo price target lowered to $10 from $11 at Canaccord
- DocGo price target lowered to $11 from $13 at Cantor Fitzgerald